Health & Lifestyle
Expert Warns of ‘Tsunami Effect’ in Uterine Cancer Incidence
Dr Mary McCormack highlights need for tailored therapies and preparedness amid projected surge in Southeast Asia
Mary McCormack, Consultant Clinical Oncologist at University College London Hospitals, has said that the treatment of uterine (womb) cancer has undergone a major transformation with the advent of immunotherapy.
Speaking in Delhi, Dr McCormack emphasised that certain groups of patients with uterine cancer can benefit significantly from immunotherapy, provided treatment is tailored based on the specific subtype of the disease. She noted that identifying cancer subtypes and administering the most suitable drugs is key to improving patient outcomes.
She also warned of a significant rise in uterine cancer cases and mortality in Southeast Asia over the next decade, describing it as a potential “tsunami effect.” According to her, healthcare systems must be prepared with strong diagnostic and treatment pathways to manage the anticipated surge.
Dr McCormack added that many patients may present with early-stage disease, which can often be effectively treated—and even cured—through surgery alone if detected in time.
The expert’s remarks underline the growing importance of early diagnosis, personalised treatment, and healthcare preparedness in tackling the rising burden of cancer globally.
